MSD (known as Merck & Co Inc. in the United States and Canada) has announced that the European Commission has granted a marketing authorisation for KEYTRUDA® (pembrolizumab) as monotherapy for...
The FDA have approved a new drug - sonidegib - for treating locally advanced basal cell carcinoma, an increasingly common cancer that occurs in the top layer of the skin.
Soldiers who served in the glaring desert sunlight of Iraq and Afghanistan returned home with an increased risk of skin cancer, due not only to the desert climate, but also a lack of sun...
A Royal Pharmaceutical Society survey into sunscreen use has revealed a worrying lack of understanding about the degree of sun protection different products provide.
Researchers at the Université libre de Bruxelles, ULB uncover a new mechanism that regulates tumour initiation and invasion in skin basal cell carcinoma.
Simon Fraser University PhD graduate Maryam Sadeghi will unveil MoleScope™, an innovative hand-held tool that uses a smartphone to monitor skin for signs of cancer, at the World Congress of...
Novartis has announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the...
The incidence of melanoma, a deadly form of skin cancer, has increased by more than 250% among children, adolescents and young adults since 1973, according to award-winning research to be presented...